A major advance in cancer research is emerging with the use of nanobodies to re-engage damaged p53. This essential malignant protector protein is frequently inactivated in several kinds of cancer, resulting https://mediajx.com/story309192/mini-antibodies-restore-p53-a-new-hope-for-cancer-management